title: [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
authors.affiliation: Servicio Hematología, Hospital de la Princesa, Madrid.
authors.forename: J L
authors.initials: JL
authors.lastname: Steegmann
authors.forename: E
authors.initials: E
authors.lastname: Granados
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez-Salvanés
authors.forename: L F
authors.initials: LF
authors.lastname: Casado
authors.forename: P
authors.initials: P
authors.lastname: Giraldo
authors.forename: E
authors.initials: E
authors.lastname: Lavilla
authors.forename: M T
authors.initials: MT
authors.lastname: Gómez-Casares
authors.forename: E
authors.initials: E
authors.lastname: Fernández-Contreras
authors.forename: J
authors.initials: J
authors.lastname: Odriozola
mesh_terms: D000328:Adult; D000465:Algorithms; D014408:Biomarkers, Tumor / Q000032:analysis; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D016044:Fusion Proteins, bcr-abl / Q000032:analysis; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D016898:Interferon-alpha; D016044:Fusion Proteins, bcr-abl
vernacular_title: Interferón alfa en el tratamiento de la leucemia mieloide crónica. Promesas, realidades y perspectivas.